Get Published | Subscribe | About | Write for Our Blog    

News RSS Bioethics News.


Investigation of generic ‘cartel’ expands to 300 drugs

External Link - Source: The Washington Post

What started as an antitrust lawsuit brought by states over just two drugs in 2016 has exploded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs, Joseph Nielsen, an assistant attorney general and antitrust investigator in Connecticut who has been a leading force in the probe, said in an interview. His comments in an interview with The Washington Post represent the first public disclosure of the dramatically expanded scale of the investigation.

This entry was posted in Uncategorized and tagged , , . Bookmark the permalink.